Dr. Angelia Bankston Mosley-williams MD

Recommended Articles

• What Is Knee Rheumatoid Arthritis?

  Knee RA refers to arthritis of the knee, an inflammatory disease that causes swelling and pain in the knee joint. The knee is one of the most common joints affected by rheumatoid arthritis. It is a serious autoimmune disorder and may cause severe pain. It may affect many of routine activities,...

• Gout: What are the Causes and Symptoms?

  Gout is a type of arthritis, characterized by pain, stiffness, and inflammation of one of the joints. If not treated, gouty arthritis may result in recurrence of the inflammation affecting tendons, joints, and other tissues. Gout is more commonly seen in men than in women.Causes of GoutGout is a...

• Fibromyalgia and Women’s Health

  Fibromyalgia is a commonly misunderstood and misdiagnosed condition. The cause of the pain and other symptoms associated with fibromyalgia are unknown. To further complicate this complex set of symptoms is the fact that women account for 90% of fibromyalgia cases. Although no research has pinpointed...

• Top 5 Natural Supplements for Lupus

  What is lupus?Lupus is a chronic autoimmune disorder wherein the immune system attacks the body’s own healthy tissues and organs. The disease leads to high levels of inflammation, which can negatively affect nearly every organ of the body such as the lungs, brain, joints, skin, heart, kidneys, as...

• Antidepressants May Offer Relief for Fibromyalgia Patients

  Today, nearly every condition that has been identified in the world of healthcare has a medication to treat it.  From heart-related issues to joint pain, drug companies have found ways to to relieve or reduce severity of some of symptoms a patient must endure.  In a study originally published in...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...